LFWD icon

ReWalk Robotics

1.50 USD
+0.01
0.67%
At close Dec 20, 4:00 PM EST
After hours
1.59
+0.09
6.00%
1 day
0.67%
5 days
-9.09%
1 month
-18.92%
3 months
-52.08%
6 months
-64.20%
Year to date
-75.92%
1 year
-68.02%
5 years
-90.56%
10 years
-99.96%
 

About: Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Employees: 108

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

11% more capital invested

Capital invested by funds: $1.82M [Q2] → $2.02M (+$203K) [Q3]

11% more funds holding

Funds holding: 19 [Q2] → 21 (+2) [Q3]

1.8% more ownership

Funds ownership: 5.28% [Q2] → 7.08% (+1.8%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$13
767%
upside
Avg. target
$13
767%
upside
High target
$13
767%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Swayampakula Ramakanth
30% 1-year accuracy
52 / 173 met price target
767%upside
$13
Buy
Reiterated
13 Nov 2024

Financial journalist opinion

Neutral
GlobeNewsWire
1 month ago
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
Research at the prestigious Semmelweis University, Budapest, Hungary has led the way in achieving government coverage in Hungary with a code for exoskeleton training that expands access to additional spinal cord injury centers
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
Neutral
Seeking Alpha
1 month ago
Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript
Lifeward Ltd. (NASDAQ:LFWD ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Mike Lawless – Chief Financial Officer Larry Jasinski – Chief Executive Officer Conference Call Participants Swayampakula Ramakanth – H.C.
Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Lifeward (LFWD) Reports Q3 Loss, Lags Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.56 per share a year ago.
Lifeward (LFWD) Reports Q3 Loss, Lags Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
Second consecutive quarter of 20 ReWalk systems sold Robust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim submission with Medicare and other U.S. payors MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Lifeward to Report Third Quarter Financial Results on November 12, 2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its third quarter 2024 financial results before the markets open on Tuesday, November 12, 2024.
Lifeward to Report Third Quarter Financial Results on November 12, 2024
Neutral
GlobeNewsWire
1 month ago
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, announced today that Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the ThinkEquity Conference on October 30, 2024.
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
Neutral
GlobeNewsWire
2 months ago
Lifeward Launches Direct Sales of AlterG Product Line in Germany
Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability
Lifeward Launches Direct Sales of AlterG Product Line in Germany
Neutral
GlobeNewsWire
3 months ago
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
Neutral
GlobeNewsWire
3 months ago
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
Neutral
GlobeNewsWire
3 months ago
Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”)
Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
Charts implemented using Lightweight Charts™